BACKGROUND:We conducted a multicenter test-negative study to estimate vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza in primary care, Europe, 2024/25. RESEARCH DESIGN AND METHODS:Specimens were collected from patients with acute respiratory infection. All or a random sample of viruses were sequenced. VE was (1-odds ratio) × 100, adjusted for confounders. RESULTS:We included 7275 cases and 17,516 controls (weeks 40-2024-18-2025). The overall VE was 46% (95% CI: 40-52), lowest in adults ≥65 years at 28% (95% CI: 12-42). VE against influenza A(H1N1)pdm09 was 30% (95% CI: 19-40); ranging 16-34% by age and vaccination target group. Most (88%) circulating clades were 5a.2a, distinct from the vaccine clade. VE was 28% (95% CI: 7-45) against 5a.2a (C.1.9), and 6% (95% CI: -62-45) against the vaccine-matched clade 5a.2a.1 (D). VE against influenza A(H3N2) was 38% (95% CI: 26-49); ranging 20-66% by age and target group. Circulating viruses belonged to the vaccine clade 2a.3a.1, with 88% subclade (J.2). VE against influenza B was 76% (95% CI: 69-81); ranging 70-80% by age and target group; all viruses belonged to the vaccine clade V1A.3a.2, with diverse subclades. CONCLUSIONS:Influenza vaccination protected approximately one in two vaccinated individuals against medically attended infection in primary care in Europe, 2024/25, varying by (sub)type and age.
Campylobacter spp. is a leading cause of community-acquired gastroenteritis, with rising antimicrobial resistance (AMR) posing a significant public health challenge. This study aimed to characterize the genomic basis of resistance and virulence in Campylobacter spp. isolated from human stool at the University Hospital of Split, Croatia. A total of 115 unduplicated isolates (100 Campylobacter jejuni and 15 Campylobacter coli) were identified and tested for antimicrobial susceptibility, from January to June 2023. A representative number of isolates with phenotypically detected resistance were analyzed with whole-genome sequencing. Multilocus sequence typing (MLST) was determined using genomic sequences as input data against the standard MLST schemes. High rates of resistance were detected to tetracycline (45% of C. jejuni and 26.7% of C. coli) and ciprofloxacin (81% of C. jejuni and 46.7% of C. coli), while combined ciprofloxacin/tetracycline resistance was observed in 43% of C. jejuni and 7% of C. coli isolates. The majority of whole-genome sequenced isolates possess tet(O/32/O) gene and gyrA.T861 mutation, conferring resistance to tetracycline and fluoroquinolones. All isolates have at least one resistance gene for β-lactams (blaOXA-61, blaOXA-193, blaOXA-450, blaOXA-451, blaOXA-452, blaOXA-461, and blaOXA-489), while 40% of isolates possess ant(6)-Ia for aminoglycoside resistance. In addition, a newly emerged, phenotypically identified multidrug-resistant C. coli, harbored tet(O/32/O) and tet(O) genes, point mutation in gyrA gene, and A2075G mutation in 23S rRNA. Virulence analysis highlighted C. jejuni's broad pathogenic potential, including motility, adherence, invasion, exotoxin production, and immune modulation (e.g., wlaN gene, linked to Guillain-Barré syndrome). On the contrary, C. coli isolates possess genes exclusively for motility. Nine different C. jejuni MLST sequence types were identified, while all C. coli isolates belong to the same 828 clonal complex. Escalating AMR and a broad spectrum of virulence in Campylobacter spp. highlight the importance of continuous surveillance on the phenotypic and genotypic level, thereby allowing more efficient health care management of these infections.
Immortelle (Helichrysum italicum (Roth) G. Don, family Asteraceae) essential oils (HiEOs) and hydrosols (HiHYs) are widely used in cosmetic, pharmaceutical, and agricultural formulations. However, their composition and quality vary depending on geographical origin and production practices, while standardized reference values-particularly for hydrosols-are still lacking. The aim of this study was to investigate and compare the physicochemical properties and chemical composition of commercial HiEOs and HiHYs from the Adriatic and continental regions of Croatia. Samples were analysed using standard pharmacopoeial methods and gas chromatography-mass spectrometry (GC-MS). Physicochemical analyses (relative density, acid value, refractive index, pH, turbidity, and essential oil content) showed that all samples were within generally accepted quality ranges, with no significant differences observed between regions using the Mann-Whitney U test. HiEOs were dominated by sesquiterpene hydrocarbons (53.15-55.60%), whereas HiHYs contained predominantly oxygenated monoterpenes (43.54-69.86%). The main compounds identified in both fractions were alpha-pinene, neryl acetate, gamma-curcumene, and beta-selinene, which formed a consistent chemical signature and served as practical biomarkers for the quality of H. italicum EO and hydrosol. Principal Component Analysis (PCA) distinguished sample groupings based on physicochemical properties and chemical composition, indicating regional variability without exceeding accepted quality limits. This study presents the first comparative dataset of Croatian commercial HiEOs and HiHYs, and defines practical parameter ranges to support standardized specifications, ensure consistent quality, and enhance the industrial applicability of immortelle-based products.
Eastern Croatia includes settlements with historically elevated arsenic (As) concentrations in drinking water. Of 488 recruited adults, nine were excluded solely because no questionnaire was available; the exclusion was independent of measured arsenic concentrations, and the harmonised analytical cohort therefore comprised 479 adults from eight settlements. Total As concentrations in drinking water, hair, serum, and urine were measured in samples collected in June 2015 by inductively coupled plasma mass spectrometry. Kidney cancer data (ICD-10 C64) for 2000–2018 were obtained from the Croatian National Cancer Registry and analysed ecologically. MDCK1 cells were exposed to As2O3 at 10–200 µg/L for 48, 72, and 96 h, and acetylcholinesterase (AChE) activity was measured in human erythrocytes. Čepin had the highest median As concentrations in drinking water (191.75 µg/L) and urine (68.14 µg/L). Across all eight settlements, drinking-water As was strongly associated with urinary As (slope = 0.537; 95% CI, 0.352–0.722; R2 = 0.894; p < 0.001). However, in a sensitivity analysis excluding Čepin and using the seven non-Čepin settlement means reported, the association weakened (r = 0.740; R2 = 0.548; slope = 1.246; 95% CI, −0.054 to 2.547; p = 0.057), indicating substantial influence of the Čepin hotspot. Associations with hair As (R2 = 0.294; p = 0.165) and serum As (R2 = 0.239; p = 0.219) were not statistically significant. In a multivariable Gamma generalized linear model, residence in Čepin was associated with higher expected urinary As than residence in Vladislavci (adjusted mean ratio, 2.90; 95% CI, 1.90–4.42; p < 0.001), while female sex was associated with a lower expected concentration (adjusted mean ratio, 0.80; 95% CI, 0.66–0.97; p = 0.024). No statistically significant effect of As2O3 on MDCK1 viability or erythrocyte AChE activity was observed. The findings support urinary total As as a biomarker of recent environmental exposure, but do not establish causal associations with kidney toxicity or kidney cancer.
Background/Objectives: Neuroradiological features of neuroinvasive Usutu virus (USUV) infection are poorly understood, as current knowledge is largely limited to case reports. This study aimed to describe brain MRI patterns, and assess disease severity and vital and functional outcomes in patients with neuroinvasive USUV infection. Methods: This multicentric retrospective observational cohort study analyzed adult patients of both sexes, aged ≥18 years, in the continental region of Croatia who developed symptoms of neuroinvasive disease during the arbovirus transmission season between 2017 and 2025. Patients with serological and/or molecular confirmation of USUV infection were included in further analyses. Only patients who underwent a brain MRI during hospitalization were included in the study. Clinical data and blood/CSF laboratory parameters were also evaluated. The observed outcomes were the severity of clinical symptoms, vital status at hospital discharge, and functional status at hospital discharge. Results: Of 214 arbovirus-positive cases, 8 patients had confirmed neuroinvasive USUV infection, and 4 had a brain MRI. Three patients were male. One patient had a normal MRI, and three patients had abnormal MRIs. All patients with abnormal MRI demonstrated meningeal contrast enhancement (a finding not previously reported), uni- or bilateral hippocampal involvement suggestive of limbic encephalitis, and basal ganglia involvement. All patients required ICU admission, experienced prolonged hospitalization, and were discharged with moderate to severe disability. Conclusions: This study provides important insights into MRI patterns in patients with neuroinvasive USUV infection and addresses the current knowledge gap regarding the neuroimaging of this underdiagnosed disease.